DeepMed Research

UNIVERSITY COLLEGE LONDON

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1826-02-11

Employees: 10K

Market Cap: -

Website: http://www.ucl.ac.uk

Clinical Trials

Preoperative Intravenous Iron to Treat Anaemia in Major Surgery

Phase 3

Completed

Conditions: Anaemia

Interventions: Drug: Normal saline
Drug: Ferric carboxymaltose

First Posted Date: 2012-09-25

Last Posted Date: 2019-06-03

Lead Sponsor: University College, London

Target Recruit Count: 487

Registration Number: NCT01692418

Locations: 🇬🇧
University College London, London, United Kingdom
🇬🇧
Broomfield Hospital, Broomfield, United Kingdom
🇬🇧
Queen Elizabeth Hospital, Gateshead, United Kingdom

and more 25 locations

Differential Effects of Lipids on Cardiovascular Diseases: A CALIBER Study

Conditions: Stable Angina
Unstable Angina
Non ST Elevation Myocardial Infarction
ST Elevation Myocardial Infarction
Myocardial Infarction Not Otherwise Specified

First Posted Date: 2012-09-19

Last Posted Date: 2012-09-19

Lead Sponsor: University College, London

Target Recruit Count: 175872

Registration Number: NCT01687686

Locations: 🇬🇧
University College London, London, Greater London, United Kingdom

Clinical and Cost Effectiveness of Positive Behaviour Support: a Trial

Phase 3

Conditions: Challenging Behaviour

Interventions: Other: Treatment as Usual
Behavioral: PBS based staff training

First Posted Date: 2012-09-07

Last Posted Date: 2016-05-23

Lead Sponsor: University College, London

Target Recruit Count: 246

Registration Number: NCT01680276

Locations: 🇬🇧
Leicestershire Foundation Trust, Leicester, United Kingdom
🇬🇧
Camden & Islington Foundation Trust, London, United Kingdom
🇬🇧
South London and St George's Mental Health Trust, London, United Kingdom

Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy

Phase 2

Completed

Conditions: Diffuse Large B Cell Lymphoma

Interventions: Drug: Cyclophosphamide
Drug: Vincristine
Drug: Prednisolone
Drug: Rituximab
Drug: Inotuzumab Ozogamicin
Drug: Gemcitabine

First Posted Date: 2012-09-05

Last Posted Date: 2022-05-18

Lead Sponsor: University College, London

Target Recruit Count: 129

Registration Number: NCT01679119

Locations: 🇬🇧
North Hampshire Hospital, Basingstoke, United Kingdom
🇬🇧
West Suffolk Hospital, Bury St Edmunds, United Kingdom
🇬🇧
University Hospital, Coventry, Coventry, United Kingdom

and more 37 locations

A Randomised Controlled Trial to Investigate the Effects of a Mindfulness Smartphone App on Well-being in the Workplace

Not Applicable

Conditions: Well-being, Work Stress

Interventions: Other: Headspace On-the-go app

First Posted Date: 2012-08-09

Last Posted Date: 2012-08-09

Lead Sponsor: University College, London

Target Recruit Count: 120

Registration Number: NCT01661569

Locations: 🇬🇧
UK high-tech company office, London, United Kingdom

Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery

Phase 2

Completed

Conditions: Rectal Cancer

Interventions: Biological: Bevacizumab
Drug: Oxaliplatin
Drug: Irinotecan
Drug: 5-Fluorouracil

First Posted Date: 2012-07-26

Last Posted Date: 2019-10-07

Lead Sponsor: University College, London

Target Recruit Count: 20

Registration Number: NCT01650428

Locations: 🇬🇧
Wexham Park Hospital, Slough, United Kingdom
🇬🇧
UCLH, London, United Kingdom
🇬🇧
Blackpool Victoria Hospital, Blackpool, United Kingdom

and more 8 locations

A Trial of Bilateral Deep Brain Stimulation to the Globus Pallidus Internum in Tourette Syndrome

Phase 2

Completed

Conditions: Tourette Syndrome

Interventions: Procedure: Bilateral GPi Deep Brain Stimulation

First Posted Date: 2012-07-23

Last Posted Date: 2015-03-19

Lead Sponsor: University College, London

Target Recruit Count: 15

Registration Number: NCT01647269

Locations: 🇬🇧
UCL Institute of Neurology, London, United Kingdom

The MRC/ABPI COPD Cohort v1.7

Conditions: COPD

Interventions: Radiation: CT scan and PA chest X-ray

First Posted Date: 2012-06-15

Last Posted Date: 2012-06-15

Lead Sponsor: University College, London

Target Recruit Count: 400

Registration Number: NCT01620645

Locations: 🇬🇧
Royal Free Hampstead NHS Trust, London, United Kingdom

A Study for Older Adults With Acute Lymphoblastic Leukaemia

Phase 2

Completed

Conditions: Acute Lymphoblastic Leukaemia

Interventions: Drug: Chemotherapy

First Posted Date: 2012-06-11

Last Posted Date: 2023-08-16

Lead Sponsor: University College, London

Target Recruit Count: 126

Registration Number: NCT01616238

Locations: 🇬🇧
NHS Lanarkshire - Monklands, Airdrie, United Kingdom
🇬🇧
Russells Hall Hospital, Dudley, United Kingdom
🇬🇧
St Helen's & Knowlsey Teaching Hospitals, Prescot, United Kingdom

and more 31 locations

Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Cancer
Fallopian Tube Cancer

Interventions: Drug: BIBF 1120

First Posted Date: 2012-06-04

Last Posted Date: 2019-05-29

Lead Sponsor: University College, London

Target Recruit Count: 117

Registration Number: NCT01610869

Locations: 🇬🇧
Kent Oncology Centre, Maidstone, Kent, United Kingdom
🇬🇧
Royal Derby Hospital, Derby, United Kingdom
🇬🇧
St James's University Hospital, Leeds, United Kingdom

and more 13 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy